Predicting final visual acuity following cataract surgery
Predicting final visual acuity following cataract surgery
批准号:
9215348
负责人:
LISA J HERRINTON
金额:
$36.96万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2019-02-28
关键词:
AddressAdoptionAdverse eventAffectAnti-Inflammatory AgentsAnti-inflammatoryBenefits and RisksBlindnessCaliforniaCataractCataract ExtractionClimactericClinicalCohort StudiesCommunitiesComorbidityComplicationComputerized Medical RecordCountryCystoid Macular EdemaDataDecision MakingDiagnosisDiagnosticDrug usageEffectivenessElectronic Health RecordEnsureEpidemicEuropeEvaluationEyeIncidenceKnowledgeLiteratureLongitudinal StudiesMeasurementMeasuresModelingModernizationOperative Surgical ProceduresOphthalmologistOptical Coherence TomographyOutcomePatientsPhacoemulsificationPharmaceutical PreparationsPhysiciansPopulationPostoperative ComplicationsPostoperative PeriodPractice GuidelinesPrevalencePreventionRecoveryReportingResearchResolutionRiskRoleSafetySubgroupSurgeonSurgical complicationTechniquesTestingThickTimeUnited StatesVisionVisualVisual AcuityVulnerable Populationsbaseclinical decision-makingclinical practiceclinical predictorsevidence baseexperienceimprovedindividual patientmacular edemaoutcome forecastpersonalized carepopulation basedpreventprognosticprophylacticprospectiverelative effectivenessresearch studystem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT: Cataract surgery is the most commonly performed surgery in the United
States. Despite this, we know surprisingly little about visual outcomes and rates of
complications following contemporary cataract surgery, especially in population subgroups. This
lack of knowledge is troubling given that emerging research from Europe suggests that cataract
surgery might be ineffective for up to 6% of patients and present significant harms to another 2-
5%. Cystoid macular edema (CME), for example, is a common postoperative complication of
cataract surgery. Since the adoption of optical coherence tomography, CME incidence has risen
from ~2% to ~40%. However, cataract surgeons lack a clear understanding of what this
diagnosis means. To address this issue, we propose a cohort study to generate real-world
knowledge about cataract surgery prognosis, including visual outcomes and complication rates;
CME diagnostic criteria that correlate with late postoperative vision loss; the prevention of
significant CME; and differences in these topics among vulnerable population subgroups. The
proposed study will include comprehensive, prospectively recorded data for approximately
186,000 patients and more than 250,000 eyes that received surgery at Kaiser Permanente
Northern California from 2007 to 2016. The study will be the largest in the U.S.; will use
detailed, comprehensive information that is prospectively recorded into the electronic medical
record; and will use modern analytic techniques to ensure valid analyses. The well-
characterized, community-based population is diverse, with 29% of patients being non-white
and 43% having an ocular comorbidity. Together with the large number of cases, this high level
of diversity will enable detailed sensitivity and subgroup analysis. Our results will allow cataract
surgeons to individualize care for their patients. The results will also provide desperately
needed evidence-based diagnostic criteria for CME. These criteria can be used in research
studies, in clinical practice, and to develop practice guidelines. The exceptional volume of
cataract surgery justifies research to improve decision-making of this life-changing surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Prophylaxis in Cataract Surgery
-
批准号:8428618
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2013
-
负责人:LISA J HERRINTON
-
依托单位:
Psoriasis treatments, cardiovascular disease, and diabetes
-
批准号:8506094
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:LISA J HERRINTON
-
依托单位:
Comparative Effectiveness of Prophylaxis in Cataract Surgery
-
批准号:8600280
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2013
-
负责人:LISA J HERRINTON
-
依托单位:
Psoriasis treatments, cardiovascular disease, and diabetes
-
批准号:8728163
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2013
-
负责人:LISA J HERRINTON
-
依托单位:
Kaiser Permanente Autoimmune Disease Registry
-
批准号:7815188
-
项目类别:
-
资助金额:$49.97万
-
财政年份:2009
-
负责人:LISA J HERRINTON
-
依托单位:
Kaiser Permanente Autoimmune Disease Registry
-
批准号:7937015
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2009
-
负责人:LISA J HERRINTON
-
依托单位:
HR-QOL in Colorectal Cancer Survivors with Stomas
-
批准号:8296695
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2004
-
负责人:LISA J HERRINTON
-
依托单位:
HR-QOL in Colorectal Cancer Survivors with Stomas
-
批准号:7653542
-
项目类别:
-
资助金额:$44.44万
-
财政年份:2004
-
负责人:LISA J HERRINTON
-
依托单位:
HR-QOL in Colorectal Cancer Survivors with Stomas
-
批准号:8465832
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2004
-
负责人:LISA J HERRINTON
-
依托单位:
HR-QOL in Colorectal Cancer Survivors with Stomas
-
批准号:8069867
-
项目类别:
-
资助金额:$41.92万
-
财政年份:2004
-
负责人:LISA J HERRINTON
-
依托单位:
HR-QOL in Colorectal Cancer Survivors with Stomas
-
批准号:7846882
-
项目类别:
-
资助金额:$41.8万
-
财政年份:2004
-
负责人:LISA J HERRINTON
-
依托单位:
Epidemiology of Marginal Zone Lymphoma
-
批准号:6665485
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2002
-
负责人:LISA J HERRINTON
-
依托单位:
Epidemiology of Marginal Zone Lymphoma
-
批准号:6584697
-
项目类别:
-
资助金额:$7.19万
-
财政年份:2002
-
负责人:LISA J HERRINTON
-
依托单位:
PREVENTIVE ONCOLOGY ACADEMIC AWARDS
-
批准号:6173047
-
项目类别:
-
资助金额:$8.65万
-
财政年份:1996
-
负责人:LISA J HERRINTON
-
依托单位:
PREVENTIVE ONCOLOGY ACADEMIC AWARDS
-
批准号:2114735
-
项目类别:
-
资助金额:$8.38万
-
财政年份:1996
-
负责人:LISA J HERRINTON
-
依托单位:
PREVENTIVE ONCOLOGY ACADEMIC AWARDS
-
批准号:2700679
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1996
-
负责人:LISA J HERRINTON
-
依托单位:
PREVENTIVE ONCOLOGY ACADEMIC AWARDS
-
批准号:2895554
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1996
-
负责人:LISA J HERRINTON
-
依托单位:
PREVENTIVE ONCOLOGY ACADEMIC AWARDS
-
批准号:2414460
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1996
-
负责人:LISA J HERRINTON
-
依托单位:
海外基金